53 publications
| Name | Date | Type | Actions |
|---|---|---|---|
2023 half-year Results Sales: €256m (-5.4% as reported) |
Public releases | ||
2023 Half-Year Results Contents |
Half Year Report | ||
Buyback programs - July Monthly communication regarding buyback programs |
Description of buyback programs | ||
Monthly information regarding the total number of voting rights - July 2023 As per articles L233‐8‐II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers » |
Voting rights | ||
Mastaplex and Vetoquinol announce distribution agreement Mastaplex Ltd (New Zealand, unlisted) and Vetoquinol (VETO: France Euronext) are pleased to announce an extension of their exclusive distribution agreement for Mastatest.. |
Press releases communication | ||
Update July 11, 2023 2023 CALENDAR OF FINANCIAL COMMUNICATION Update July 11, 2023 |
Agenda | ||
Rapport financier semestriel 2022 (french) Rapport financier semestriel 2022 (french) |
Half Year Report | ||
Growth driven by innovation Ever since the company was founded in 1933, innovation has been a major component of Vetoquinol's development strategy. |
Press releases communication | ||
Rémunération et politique des dirigeants - mai 2023 (french) Rémunération et politique des dirigeants |
Shareholders´s Meeting | ||
Vetoquinol - assemblée générale mixte - 25 mai 2023 : résultat du scrutin |
Shareholders´s Meeting |